Gossamer Bio, Inc.

NasdaqGS:GOSS Stock Report

Market Cap: US$167.4m

Gossamer Bio Management

Management criteria checks 4/4

Gossamer Bio's CEO is Faheem Hasnain, appointed in Nov 2020, has a tenure of 3.5 years. total yearly compensation is $2.10M, comprised of 29% salary and 71% bonuses, including company stock and options. directly owns 2.28% of the company’s shares, worth $3.82M. The average tenure of the management team and the board of directors is 3.2 years and 4.2 years respectively.

Key information

Faheem Hasnain

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage29.0%
CEO tenure3.5yrs
CEO ownership2.3%
Management average tenure3.2yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

Peaking Back In On Gossamer Bio

Sep 27

Gossamer Bio to raise $120M in a private equity placement

Jul 13

Health Check: How Prudently Does Gossamer Bio (NASDAQ:GOSS) Use Debt?

Jun 25
Health Check: How Prudently Does Gossamer Bio (NASDAQ:GOSS) Use Debt?

Gossamer Bio (NASDAQ:GOSS) Has Debt But No Earnings; Should You Worry?

Jan 19
Gossamer Bio (NASDAQ:GOSS) Has Debt But No Earnings; Should You Worry?

Is Gossamer Bio (NASDAQ:GOSS) A Risky Investment?

Sep 22
Is Gossamer Bio (NASDAQ:GOSS) A Risky Investment?

Need To Know: Gossamer Bio, Inc. (NASDAQ:GOSS) Insiders Have Been Buying Shares

Jan 28
Need To Know: Gossamer Bio, Inc. (NASDAQ:GOSS) Insiders Have Been Buying Shares

Gossamer Bio (GOSS) Investor Presentation - Slideshow

Nov 18

CEO Compensation Analysis

How has Faheem Hasnain's remuneration changed compared to Gossamer Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$2mUS$607k

-US$180m

Sep 30 2023n/an/a

-US$187m

Jun 30 2023n/an/a

-US$207m

Mar 31 2023n/an/a

-US$221m

Dec 31 2022US$7mUS$592k

-US$229m

Sep 30 2022n/an/a

-US$230m

Jun 30 2022n/an/a

-US$231m

Mar 31 2022n/an/a

-US$234m

Dec 31 2021US$5mUS$574k

-US$234m

Sep 30 2021n/an/a

-US$242m

Jun 30 2021n/an/a

-US$240m

Mar 31 2021n/an/a

-US$247m

Dec 31 2020US$1mUS$72k

-US$243m

Sep 30 2020n/an/a

-US$233m

Jun 30 2020n/an/a

-US$224m

Mar 31 2020n/an/a

-US$202m

Dec 31 2019US$1mUS$200k

-US$180m

Sep 30 2019n/an/a

-US$164m

Jun 30 2019n/an/a

-US$165m

Mar 31 2019n/an/a

-US$154m

Dec 31 2018US$19mUS$470k

-US$147m

Compensation vs Market: Faheem's total compensation ($USD2.10M) is about average for companies of similar size in the US market ($USD1.64M).

Compensation vs Earnings: Faheem's compensation has been consistent with company performance over the past year.

CEO

Faheem Hasnain (65 yo)

3.5yrs

Tenure

US$2,095,988

Compensation

Mr. Faheem Hasnain has been Chief Executive Officer and President at Gossamer Bio, Inc. since November 16, 2020. He serves as Executive Advisor at Vertex Ventures HC since joining the firm on October 29, 2...

Leadership Team

NamePositionTenureCompensationOwnership
Faheem Hasnain
Co-Founder3.5yrsUS$2.10m2.28%
$ 3.8m
Bryan Giraudo
COO & CFO6yrsUS$1.29m0.21%
$ 349.8k
Robert Smith
Chief Commercial Officerless than a yearUS$1.33mno data
Christian Waage
Executive Vice President of Technical Operations & Administration2.2yrsUS$1.65m0.29%
$ 484.0k
Jeff Boerneke
General Counsel & Secretary3.3yrsno datano data
Deanna Weber
Senior Vice President of Human Resourcesno datano datano data
Richard Aranda
Chief Medical Officerno dataUS$2.48m0.089%
$ 149.0k
Mario Orlando
Senior Vice President of Commercial New Product Planning2.2yrsno datano data
Caryn Peterson
Executive Vice President of Regulatory Affairsno datano data0.022%
$ 36.9k
Matt Cravets
Senior Vice President of Biometrics3.2yrsno datano data
Lisa Nolan
MD & President of Gossamer Bio Ireland2.3yrsno datano data
Colin Rowlings
Senior Vice President of CMC3.2yrsno datano data

3.2yrs

Average Tenure

60yo

Average Age

Experienced Management: GOSS's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Faheem Hasnain
Co-Founder8.6yrsUS$2.10m2.28%
$ 3.8m
Russell Cox
Independent Director5.5yrsUS$87.32k0.0032%
$ 5.3k
Thomas Daniel
Lead Independent Director6.3yrsUS$98.82k0.017%
$ 28.2k
John Quisel
Independent Directorless than a yearUS$133.61kno data
Renee Gala
Independent Director5.4yrsUS$86.82k0%
$ 0
Sandra Milligan
Independent Director2.9yrsUS$81.82k0.014%
$ 23.7k
Steven Nathan
Independent Directorless than a yearno datano data
Skye Drynan
Independent Directorless than a yearno datano data

4.2yrs

Average Tenure

59.5yo

Average Age

Experienced Board: GOSS's board of directors are considered experienced (4.2 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.